SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹19 Cr | ₹18 Cr | ₹6.07 Cr | ₹6.07 Cr | ₹6.07 Cr |
What is the latest Contingent Liabilities ratio of SUVEN PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹6.07 Cr |
| Mar2022 | ₹6.07 Cr |
| Mar2021 | ₹6.07 Cr |
How is Contingent Liabilities of SUVEN PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | 3.53 | |
| Mar2024 | ₹18 Cr | 198.50 | |
| Mar2023 | ₹6.07 Cr | 0.00 | |
| Mar2022 | ₹6.07 Cr | 0.00 | |
| Mar2021 | ₹6.07 Cr | - | |
Compare Contingent Liabilities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹14,194.5 Cr | -2.6% | -29.1% | -62.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | 1.2% | -5.3% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -3.9% | -6% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | 0.9% | 3.7% | 20.5% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | -1.2% | -12.6% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -3.4% | -5.7% | 0.3% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -2.6% |
-29.1% |
-62.1% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses